Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy

Supportive Care in Cancer

Volumn 22, Issue 5, 2014, Pages 1233-1242

  Hovey, Elizabeth ^a,b   De Souza, Paul ^c   Marx, Gavin ^d   Parente, Phillip ^e   Rapke, Tal ^f   Hill, Andrew ^g   Bonaventura, Antonino ^h   Michele, Antony ⁱ   Craft, Paul ^j   Abdi, Ehtesham ^k,l   Lloyd, Andrew ^b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

^d Sydney Haematology Oncology Clinic   (Australia)

^e BOX HILL HOSPITAL   (Australia)

^f Sanofi Australia Pty Ltd   (Australia)

^g GOLD COAST UNIVERSITY HOSPITAL   (Australia)

^h ANZGOG   (Australia)

ⁱ Calvary Hospital   (Australia)

^j CANBERRA HOSPITAL   (Australia)

^k Tweed Hospital   (Australia)

^l GRIFFITH UNIVERSITY   (Australia)

more..

Author keywords

Breast cancer; Chemotherapy; Docetaxel; Fatigue; Modafinil; Prostate cancer

Indexed keywords

DOCETAXEL; MODAFINIL; PLACEBO;

ABDOMINAL PAIN; AGED; AGITATION; ANEMIA; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER FATIGUE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HEADACHE; HUMAN; INFECTION; INJECTION SITE PAIN; INSOMNIA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MD ANDERSON SYMPTOM INVENTORY; MEDICATION COMPLIANCE; MOOD DISORDER; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NAUSEA AND VOMITING; NEUTROPENIA; PAIN; PANCYTOPENIA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BENZHYDRYL COMPOUNDS; BREAST NEOPLASMS; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; NAUSEA; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; TAXOIDS; VOMITING; WAKEFULNESS-PROMOTING AGENTS;

EID: 84897540616     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-2076-0     Document Type: Article

References (30)

1. Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR (2007) Cancer-related fatigue: the scale of the problem. Oncologist 12(Suppl 1):4-10
2. Bower JE, Lamkin DM (2013) Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications. Brain Behav Immun 30:S48-S57
3. Miller AH (2009) Norman cousins lecture. mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface. Brain Behav Immun 23(2):149-158
4. Ryan JL, Carroll JK, Ryan EP, Mustian KM, Fiscella K, Morrow GR (2007) Mechanisms of cancer-related fatigue. Oncologist 12(Suppl 1):22-34
5. Iop A, Manfredi AM, Bonura S (2004) Fatigue in cancer patients receiving chemotherapy: an analysis of published studies. Ann Oncol 15(5):712-720 (Pubitemid 38714731)
6. Stone PC, Minton O (2008) Cancer-related fatigue. Eur J Cancer 44(8):1097-1104
7. Jacobsen PB, Donovan KA, Vadaparampil ST, Small BJ (2007) Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue. Health Psychol 26(6):660-667 (Pubitemid 350161067)
8. Minton O, Richardson A, Sharpe M, Hotopf M, Stone PC (2011) Psychostimulants for the management of cancer-related fatigue: a systematic review and meta-analysis. J Pain Symptom Manage 41(4):761-767
9. Minton O, Richardson A, Sharpe M, Hotopf M, Stone P (2010) Drug therapy for the management of cancer-related fatigue. Cochrane Database Syst Rev 7:CD006704
10. Minton O, Richardson A, Sharpe M, Hotopf M, Stone P (2008) A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer Inst 100(16):1155-1166
11. Golicki D, Bala MM, Niewada M, Wierzbicka A (2010) Modafinil for narcolepsy: systematic review and meta-analysis. Med Sci Monit 16(8):RA177-RA186
12. Brown JN, Howard CA, Kemp DW (2010) Modafinil for the treatment of multiple sclerosis-related fatigue. Ann Pharmacother 44(6):1098-1103
13. Saavedra-Velez C, Yusim A, Anbarasan D, Lindenmayer JP (2009) Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review. J Clin Psychiatry 70(1):104-112
14. Kumar R (2008) Approved and investigational uses of modafinil : an evidence-based review. Drugs 68(13):1803-1839
15. Wirz S, Nadstawek J, Kuhn KU, Vater S, Junker U, Wartenberg HC (2010) Modafinil for the treatment of cancer-related fatigue : an intervention study. Schmerz 24(6):587-595
16. Kaleita TA, Wellisch DK, Graham CA, Steh B, Nghiemphu P, Ford JM et al (2006) Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adults patients with brain tumors. J Clin Oncol (Meeting Abstracts) 24(Suppl 18):1503
17. Spathis A, Dhillan R, Booden D, Forbes K, Vrotsou K, Fife K (2009) Modafinil for the treatment of fatigue in lung cancer: a pilot study. Palliat Med 23(4):325-331
18. Blackhall L, Petroni G, Shu J, Baum L, Farace E (2009) A pilot study evaluating the safety and efficacy of modafinal for cancer-related fatigue. J Palliat Med 12(5):433-439
19. Morrow GR, Ryan JL, Kohli S, et al. (2006) Modafinil (Provigil®) for persistent post-treatment fatigue: an open label study of 82 women with breast cancer. Abstracts of the 18th MASCC International Symposium, Toronto; Supportive Care in Cancer; 583-687
20. Jean-Pierre P, Morrow GR, Roscoe JA, Heckler C, Mohile S, Janelsins M et al (2010) A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect ofmodafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Research base study. Cancer 116(14):3513-3520
21. Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M et al (2000) Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer 89(7):1634-1646
22. Hadzi-Pavlovic D, Hickie IB, Wilson AJ, Davenport TA, Lloyd AR, Wakefield D (2000) Screening for prolonged fatigue syndromes: validation of the SOFA scale. Soc Psychiatry Psychiatr Epidemiol 35(10):471-479
23. Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN et al (2004) Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 351(15):1502-1512 (Pubitemid 39315317)
24. Brown H, Prescott R (eds) (2006) Applied mixed models in medicine, 2nd edn. John Wiley and Sons, New Jersey
25. Sloan JA, Cella D, Hays RD (2005) Clinical significance of patient-reported questionnaire data: another step toward consensus. J Clin Epidemiol 58(12):1217-1219 (Pubitemid 41608536)
26. Barton DL, Liu H, Dakhil SR et al (2012) Phase III evaluation of American ginseng (Panax quinquefolius) to improve cancer-related fatigue: NCCTG trial N07C2. J Clin Oncol 30(Suppl):9001, Abstract
27. Yennurajalingam S, Frisbee-Hume S, Palmer JL, Gado-Guay MO, Bull J, Phan AT et al (2013) Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol 31(25):3076-3082
28. Stankoff B, Waubant E, Confavreux C, Edan G, Debouverie M, Rumbach L et al (2005) Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study. Neurology 64(7):1139-1143
29. Fife K, Spathis A, Dutton S, et al. (2013) A multicenter, randomized, double-blinded, placebo-controlled trial of modafinil for lung cancer-related fatigue: dose response and patient satisfaction data. J Clin Oncol 31[Suppl]
30. Jean-Pierre P, Figueroa-Moseley CD, Kohli S, Fiscella K, Palesh OG, Morrow GR (2007) Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment. Oncologist 12(Suppl 1):11-21